E.R. Squibb & Sons, L.L.C. drugs
14 results
Augtyro (repotrectinib)
(repotrectinib)E.R. Squibb & Sons, L.L.C.
Usage: AUGTYRO is indicated for adult patients with locally advanced or metastatic ROS1-positive non-small cell lung cancer (NSCLC) and for adult and pediatric patients aged 12 and older with locally advanced or metastatic solid tumors harboring NTRK gene fusions that have progressed after treatment or lack alternatives.
Cobenfy (xanomeline and trospium chloride)
(xanomeline and trospium chloride)E.R. Squibb & Sons, L.L.C.
Usage: COBENFY is indicated for the treatment of schizophrenia in adults.
Droxia (hydroxyurea)
(HYDROXYUREA)E.R. Squibb & Sons, L.L.C.
Usage: DROXIA is indicated for reducing the frequency of painful crises and the need for blood transfusions in patients with sickle cell anemia who experience recurrent moderate to severe painful crises.
Eliquis (apixaban)
(apixaban)E.R. Squibb & Sons, L.L.C.
Usage: ELIQUIS is indicated for reducing stroke risk in nonvalvular atrial fibrillation, preventing deep vein thrombosis after hip or knee surgery, and treating deep vein thrombosis and pulmonary embolism. It also helps reduce the risk of recurrence of DVT and PE, and treats venous thromboembolism in pediatric patients after initial therapy.
Empliciti (elotuzumab)
(elotuzumab)E.R. Squibb & Sons, L.L.C.
Usage: EMPLICITI is indicated for treating adult patients with multiple myeloma in combination with lenalidomide and dexamethasone after one to three prior therapies, or with pomalidomide and dexamethasone after at least two prior therapies, including lenalidomide and a proteasome inhibitor.
Evotaz (atazanavir and cobicistat)
(atazanavir and cobicistat)E.R. Squibb & Sons, L.L.C.
Usage: EVOTAZ® is indicated for the treatment of HIV-1 infection in adults and pediatric patients weighing at least 35 kg, used in combination with other antiretroviral agents. Treatment in experienced patients should consider baseline protease inhibitor resistance.
Nulojix (belatacept)
(BELATACEPT)E.R. Squibb & Sons, L.L.C.
Usage: NULOJIX® (belatacept) is indicated for the prevention of organ rejection in adult kidney transplant recipients. It should be used alongside basiliximab, mycophenolate mofetil, and corticosteroids, but only in EBV seropositive patients. Its efficacy for other transplanted organs is not established.
Opdivo (nivolumab)
(nivolumab)E.R. Squibb & Sons, L.L.C.
Usage: OPDIVO is indicated for the treatment of various cancers, including unresectable or metastatic melanoma, non-small cell lung cancer (NSCLC), malignant pleural mesothelioma, advanced renal cell carcinoma (RCC), classical Hodgkin lymphoma, and more, in both adults and pediatric patients. It can be used alone or in combination therapies.
Opdualag (nivolumab and relatlimab-rmbw)
(nivolumab and relatlimab-rmbw)E.R. Squibb & Sons, L.L.C.
Usage: OPDUALAG™ is indicated for treating adult and pediatric patients aged 12 and older with unresectable or metastatic melanoma.
Orencia (abatacept)
(abatacept)E.R. Squibb & Sons, L.L.C.
Usage: ORENCIA® is indicated for treating moderately to severely active rheumatoid arthritis in adults, and for patients aged 2 and older with polyarticular juvenile idiopathic arthritis or active psoriatic arthritis. It also provides prophylaxis for acute graft versus host disease in hematopoietic stem cell transplant patients.